By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytoDyn 

5 Centerpointe Drive
Suite 400
Lake Oswego  Oregon  97035  U.S.A.
Phone: 971-204-0382 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
CytoDyn Information Now Available Through S&P Capital IQ Corporation Records Program 11/25/2014 9:36:38 AM
CytoDyn Announces 100% Success With PRO 140 In Four-Week Monotherapy Clinical Trial 10/13/2014 8:06:38 AM
CytoDyn Announces Investment Community Call To Discuss Results From Its Treatment Substitution Clinical Trial In Patients With HIV 10/13/2014 7:42:21 AM
CytoDyn Appoints Carl Dockery To Board Of Directors 10/2/2014 7:47:26 AM
CytoDyn Announces Webcast For Annual Shareholder Meeting 8/18/2014 7:01:27 AM
CytoDyn Announces Investment Community Call To Discuss Interim Results From Its Treatment Substitution Study In Patients With HIV 7/31/2014 8:59:56 AM
CytoDyn Announces Positive Interim Results From Its Treatment Substitution Study in Patients With HIV 7/31/2014 6:56:44 AM
CytoDyn Announces Investor Call To Provide Update On Clinical Development Strategy 5/15/2014 11:38:21 AM
CytoDyn Announces First HIV Patient Dosing With PRO 140 In Phase 2b Clinical Trial For Treatment Substitution Protocol 5/14/2014 11:45:54 AM
CytoDyn Announces Investor Call To Provide Update On Clinical Development Strategy 3/19/2014 9:06:58 AM
12345678910...
//-->